|
|
Blood, 15 December 2007, Vol. 110, No. 13, pp. 4503-4510.
Prepublished online as a Blood First Edition Paper on August 22, 2007; DOI 10.1182/blood-2007-06-097964.
Previous Article | Table of Contents | Next Article 
RED CELLS
Tissue-specific histone modification and transcription factor binding in globin gene expression
Marco De Gobbi1,
Eduardo Anguita1,
Jim Hughes1,
Jacqueline A. Sloane-Stanley1,
Jacqueline A. Sharpe1,
Christoph M. Koch2,
Ian Dunham2,
Richard J. Gibbons1,
William G. Wood1, and
Douglas R. Higgs1
1 Medical Research Council, Molecular Haematology Unit, Weatherall Institute of Molecular Medicine, Oxford University, Oxford, United Kingdom; and
2 Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hixton, United Kingdom
To address the mechanism by which the human globin genes are activated during erythropoiesis, we have used a tiled microarray to analyze the pattern of transcription factor binding and associated histone modifications across the telomeric region of human chromosome 16 in primary erythroid and nonerythroid cells. This 220-kb region includes the globin genes and 9 widely expressed genes flanking the globin locus. This un-biased, comprehensive analysis of transcription factor binding and histone modifications (acetylation and methylation) described here not only identified all known cis-acting regulatory elements in the human globin cluster but also demonstrated that there are no additional erythroid-specific regulatory elements in the 220-kb region tested. In addition, the pattern of histone modification distinguished promoter elements from potential enhancer elements across this region. Finally, comparison of the human and mouse orthologous regions in a unique mouse model, with both regions coexpressed in the same animal, showed significant differences that may explain how these 2 clusters are regulated differently in vivo.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
| |